Successful Application of Alpha Lipoic Acid Niosomal Formulation in Cerebral Ischemic Reperfusion Injury in Rat Model
Tóm tắt
Purpose: Free radicals such as hydroxyl and peroxide are contributing factors to neuronaldestruction in cerebral ischemia. Alpha-lipoic acid (ALA) is one of the potent knownantioxidants. Preparation of ALA niosomes allows IV injection and can increase bioavailabilityand penetration into the central nervous system (CNS).Methods: Film hydration method was used to prepare different niosomes composed of Span®,Tween®, and cholesterol at different molar ratio. ALA and niosome-forming compounds weredissolved in chloroform, before removing the organic solvent by rotary evaporator. Animalswere randomly divided into four groups: Sham, control group, intravenous (IV) injection ofempty niosomes plus intraperitoneal (IP) injection of ALA solution, and finally, IV injectionof ALA niosomes. Rats were subjected to deep anesthesia before inducing cerebral ischemia,then, their internal common carotid arteries were clamped for 15 min and reperfusion wasdone for 30 min. Niosomal ALA was injected intravenously just before declamping.Results: Mean volume diameter of the prepared niosomes was between 4.36 ± 0.82 and 19.95± 1.21 μm in different formulations. Encapsulation efficiency percent (EE%) of ALA in theselected formulation, Span60/Tween60/cholesterol (35:35:30 molar ratio), was 94.5 ± 0.2, and59.27 ± 5.61% of ALA was released after 4h. In the niosomal group, the rate of reduction incomplications of cerebral ischemia such as histopathologic changes and acute damage (fromscore 3 to 1) in CNS was higher than other groups.Conclusion: The obtained results show that niosomes can be used as effective drug deliverysystems for ALA in cerebral ischemia.
Từ khóa
Tài liệu tham khảo
Huerta AE, Fernández-Galilea M, Prieto-Hontoria PL, Martínez JA, Moreno-Aliaga MJ. Alpha-lipoic acid: a dietary supplement with therapeutic potential for obesity and related metabolic diseases. In: Nabavi SM, Silva AS, eds. Nonvitamin and Nonmineral Nutritional Supplements. Academic Press; 2019. p. 85-92. doi: 10.1016/B978-0-12-812491-8.00011-4.
Pardakhty A. Non-ionic surfactant vesicles (niosomes) as new drug delivery systems. In: Information Reso Management Association, ed. Pharmaceutical Sciences: Breakthroughs in Research and Practice. Hershey, PA: IGI Global; 2017. p. 154-84.
Agarwal S, 2004, Effect of cholesterol content and surfactant HLB on vesicle properties of niosomes, Indian J Pharm Sci, 66, 121
Nowroozi F, 2018, Effect of surfactant type, cholesterol content and various downsizing methods on the particle size of niosomes, Iran J Pharm Res, 17, 1
Essa EA, 2014, Effect of formulation and processing variables on the particle size of sorbitan monopalmitate niosomes, Asian J Pharm, 4, 227, 10.4103/0973-8398.76752
Jain A, Jain SK. In vitro release kinetics model fitting of liposomes: an insight. Chem Phys Lipids 2016. doi: 10.1016/j.chemphyslip.2016.10.005.
Skibska B, 2006, Protective effects of early administration of alpha-lipoic acid against lipopolysaccharide-induced plasma lipid peroxidation, Pharmacol Rep, 58, 399